Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy

BACKGROUND: Although immunotherapy (IMT) provides significant survival benefits in selected patients, approximately 10% of patients experience (serious) immune-related adverse events (irAEs). The early detection of adverse events will prevent irAEs from progressing to severe stages, and routine test...

Descripción completa

Detalles Bibliográficos
Autores principales: van Delft, Frederik, Muller, Mirte, Langerak, Rom, Koffijberg, Hendrik, Retèl, Valesca, van den Broek, Daan, IJzerman, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295956/
https://www.ncbi.nlm.nih.gov/pubmed/33813943
http://dx.doi.org/10.1177/0272989X211002756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295956/
https://www.ncbi.nlm.nih.gov/pubmed/33813943
http://dx.doi.org/10.1177/0272989X211002756

Ejemplares similares